Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CannaRoyalty Corp C.CRZ

Origin House is a growing cannabis product and brands company operating across key markets in the U.S. and Canada. The company delivers over 130 branded cannabis products to the licensed dispensaries. It provides distribution, manufacturing, cultivation and marketing services for its brand partners. The company operates through two operating segments, The Corporate segment derives income from non-operating investment and The California Operations segment engaged in cultivation, manufacturing, an


CSE:CRZ - Post by User

Comment by Oldweedon Apr 07, 2019 12:51pm
55 Views
Post# 29593682

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Merged Co.’s market cap

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Merged Co.’s market cap Yes the House of Brands approach is very compelling as this gives them great insight as to what sells and what the market wants, at present that AI data is gold as brands develope in the USA. Brands (especially premium brands) are where the big rec money will be made, imo and I absolutely love the idea we have a former NIKE brand executive in charge of brand developement at CL. Combine that with the data mining of OH's AI in California and sky's the limit with MED and REC. I have nott looked into the CBD path for the new combined comapany but if they have do not already have some products in the lineup I'm sure that will be the next focus. Using sales and brand as the focus instead of the LP capacity really helps stabalize the downside of this stock. I'm very excited about having a long position in this one.
<< Previous
Bullboard Posts
Next >>